Professional Advisory Services Has Decreased Resmed (RMD) Stake; Kosmos Energy LTD (KOS)’s Sentiment Is 1.78

May 18, 2018 - By Peter Erickson

Kosmos Energy Ltd. (NYSE:KOS) Logo

Professional Advisory Services Inc decreased Resmed Inc. (RMD) stake by 21.88% reported in 2017Q4 SEC filing. Professional Advisory Services Inc sold 38,741 shares as Resmed Inc. (RMD)’s stock rose 14.30%. The Professional Advisory Services Inc holds 138,352 shares with $11.72M value, down from 177,093 last quarter. Resmed Inc. now has $14.48B valuation. The stock decreased 0.94% or $0.96 during the last trading session, reaching $101.43. About 486,227 shares traded. ResMed Inc. (NYSE:RMD) has risen 35.71% since May 18, 2017 and is uptrending. It has outperformed by 24.16% the S&P500.

Kosmos Energy LTD (KOS) investors sentiment increased to 1.78 in 2017 Q4. It’s up 0.49, from 1.29 in 2017Q3. The ratio is more positive, as 87 investment managers increased or opened new stock positions, while 49 decreased and sold their holdings in Kosmos Energy LTD. The investment managers in our database now possess: 389.60 million shares, down from 401.77 million shares in 2017Q3. Also, the number of investment managers holding Kosmos Energy LTD in top ten stock positions decreased from 4 to 3 for a decrease of 1. Sold All: 11 Reduced: 38 Increased: 54 New Position: 33.

Kosmos Energy Ltd. explores for and produces gas and oil in Africa and South America. The company has market cap of $2.98 billion. The Company’s asset portfolio includes production and other development projects in offshore Ghana, as well as exploration licenses with hydrocarbon potential offshore Sao Tome and Principe, Suriname, Morocco, and Western Sahara. It currently has negative earnings.

Ratings analysis reveals 100% of Kosmos Energy’s analysts are positive. Out of 2 Wall Street analysts rating Kosmos Energy, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. KOS was included in 2 notes of analysts from August 31, 2016. The stock of Kosmos Energy Ltd. (NYSE:KOS) earned “Buy” rating by Citigroup on Tuesday, December 20. The stock of Kosmos Energy Ltd. (NYSE:KOS) has “Outperform” rating given on Wednesday, August 31 by RBC Capital Markets.

The stock increased 1.48% or $0.11 during the last trading session, reaching $7.52. About 1.82M shares traded. Kosmos Energy Ltd. (KOS) has risen 2.34% since May 18, 2017 and is uptrending. It has underperformed by 9.21% the S&P500.

Analysts await Kosmos Energy Ltd. (NYSE:KOS) to report earnings on August, 6. They expect $-0.01 EPS, up 50.00% or $0.01 from last year’s $-0.02 per share. After $-0.06 actual EPS reported by Kosmos Energy Ltd. for the previous quarter, Wall Street now forecasts -83.33% EPS growth.

Warburg Pincus Llc holds 12.7% of its portfolio in Kosmos Energy Ltd. for 91.51 million shares. Sailingstone Capital Partners Llc owns 22.45 million shares or 4.45% of their US portfolio. Moreover, Encompass Capital Advisors Llc has 3.61% invested in the company for 3.71 million shares. The United Kingdom-based Genesis Asset Managers Llp has invested 2.57% in the stock. Blackstone Group L.P., a New York-based fund reported 53.05 million shares.

More news for Kosmos Energy Ltd. (NYSE:KOS) were recently published by:, which released: “Benzinga’s Top Upgrades, Downgrades For May 17, 2018” on May 17, 2018.‘s article titled: “22 Stocks Moving In Thursday’s Pre-Market Session” and published on May 17, 2018 is yet another important article.

Investors sentiment increased to 1.51 in Q4 2017. Its up 0.16, from 1.35 in 2017Q3. It increased, as 19 investors sold RMD shares while 99 reduced holdings. 60 funds opened positions while 118 raised stakes. 86.81 million shares or 0.12% more from 86.71 million shares in 2017Q3 were reported. California Public Employees Retirement System reported 0.04% stake. Bahl & Gaynor reported 192,780 shares or 0.17% of all its holdings. 123,146 were reported by Chevy Chase Hldg. Visionary Asset Mgmt Inc stated it has 0.07% in ResMed Inc. (NYSE:RMD). 130,836 are held by National Bank & Trust Of America De. State Of Alaska Department Of Revenue reported 0.06% of its portfolio in ResMed Inc. (NYSE:RMD). Hartford Mgmt Company accumulated 0.05% or 29,399 shares. Dynamic Advisors Solutions Ltd Liability invested 0.23% in ResMed Inc. (NYSE:RMD). Tru Department Mb Fin Bancorp N A stated it has 0% in ResMed Inc. (NYSE:RMD). Bb&T Securities Ltd Company owns 0.01% invested in ResMed Inc. (NYSE:RMD) for 13,153 shares. 689,671 are owned by Schwab Charles Investment. Callahan Advsr Ltd Com accumulated 19,920 shares or 0.33% of the stock. Ent Fin Corp holds 0% or 17 shares. Everence Mgmt Inc invested in 0.06% or 3,458 shares. Carnegie Asset Mgmt Ltd Company holds 0.06% or 6,730 shares.

Since January 2, 2018, it had 0 insider purchases, and 20 insider sales for $8.72 million activity. Sandercock Brett had sold 2,000 shares worth $198,720. 28,403 shares were sold by PACE GARY W, worth $2.77M. $58,914 worth of stock was sold by Hollingshead James on Monday, April 2. On Tuesday, April 3 the insider PENDARVIS DAVID sold $270,294. 4,885 shares were sold by TAYLOR RONALD R, worth $487,083. McHale Richard also sold $200,240 worth of ResMed Inc. (NYSE:RMD) shares. 25,934 shares were sold by WAREHAM JOHN P, worth $2.65M.

Analysts await ResMed Inc. (NYSE:RMD) to report earnings on August, 7. They expect $0.92 EPS, up 19.48% or $0.15 from last year’s $0.77 per share. RMD’s profit will be $131.32M for 27.56 P/E if the $0.92 EPS becomes a reality. After $0.92 actual EPS reported by ResMed Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Among 14 analysts covering ResMed Inc (NYSE:RMD), 3 have Buy rating, 3 Sell and 8 Hold. Therefore 21% are positive. ResMed Inc had 45 analyst reports since August 3, 2015 according to SRatingsIntel. On Wednesday, August 2 the stock rating was maintained by Piper Jaffray with “Hold”. JP Morgan maintained ResMed Inc. (NYSE:RMD) on Monday, October 30 with “Overweight” rating. BMO Capital Markets maintained the stock with “Hold” rating in Friday, June 16 report. The stock has “Overweight” rating by JP Morgan on Tuesday, January 24. Jefferies maintained ResMed Inc. (NYSE:RMD) on Friday, June 2 with “Sell” rating. Jefferies maintained ResMed Inc. (NYSE:RMD) rating on Tuesday, August 1. Jefferies has “Sell” rating and $5600 target. The company was upgraded on Friday, January 22 by Credit Suisse. Barclays Capital downgraded it to “Underweight” rating and $52 target in Tuesday, January 19 report. The rating was downgraded by Macquarie Research on Tuesday, January 23 to “Sell”. JP Morgan downgraded ResMed Inc. (NYSE:RMD) on Friday, April 21 to “Neutral” rating.

ResMed Inc. (NYSE:RMD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: